Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology Midterm (edit) > Lecture 2 Part 1 > Flashcards

Lecture 2 Part 1 Flashcards

1
Q

therapeutic and/or toxic effects of drugs result from what?

A

their interactions with molecules within patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

true or false

all drugs act by associating with specific receptors (macromolecules) in ways that alter the receptor’s biochemical or biophysical activities

A

FALSE

most, but not all

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

“the component of a cell or organism that interacts with a drug and initiates the chain of biochemical events leading to the drug’s observed effects”

A

drug receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the “chain of biochemical events” that occurs when the receptor interacts with the drug

A

signal transduction pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what has become the central focus of investigation of drug effects and their mechanism of action?

A

drug receptors
(pharmacodynamics)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what 2 people observed things that made drug receptors the central focus of investigation of drug effects/mechanism of action

A

John Langley
Paul Erlich

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what did john langley notice

A

Curare did not prevent the electrical stimulation of muscle contraction, but DID block contraction that was triggered by nicotine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what did Paul Erlich discover

A

some synthetic organic agents had anti-parasitic effects while other agents didn’t

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name 4 ways in which the receptor has important practical consequences for the development of new drugs and therapeutic decisions

A

-receptors are sites of binding for drugs

-receptors are responsible for selectivity of drug action

-receptors mediate the actions of both AGONISTS AND ANTAGONISTS (both need to bind)

-receptors determine the quantitative relationships between dose/concentration of a drug and pharmacological effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what properties are important for selectivity

A

size
shape
charge
atomic composition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

true or false

receptors mediate the action of agonists but not antagonists

A

FALSE - both.
both need to bind to the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

true or false

all receptors are proteins

A

FALSE - most receptors are proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the BEST CHARACTERIZED drug receptors?

A

regulatory proteins that mediate the actions of endogenous chemicals signals

(like neurotransmitters, hormones, and autacoids)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

besides regulatory proteins that mediate actions of endogenous chemicals, name 3 other classes of proteins that have been clearly identified as drug receptors

A

-enzymes
-transport proteins
-structural proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

true or false

enzymes are receptors

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

true or false

enzymes are receptors that may be inhibited or activated by drugs

A

true, but inhibit is more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

give an example of an enzyme that is a receptor for a drug

A

DHFR (dihydrofolate reductase) is the receptor for methotrexate (antineoplastic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

give an example of how transport proteins can be drug receptors

A

the receptor for cardioactive digitalis glycosides = Na+/K+ ATPase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how can structural proteins function as drug receptors

A

tubulin = protein involved to maintain cellular integrity.

tubulin = receptor for colchicine – an anti-inflamm agent for gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the receptor for colchicine

A

tubulin (a structural protein)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the receptor for methotrexate

A

DHFR (enzyme)

dihydro folate reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

when is the relationship between dose and response potentially quite complex? when is it simple and can be described with mathematical precision

A

complex - when administered to a human

simple - in vitro studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

in intact patients or animals, the responses to low doses of drug usually ________ in proportion to dose.

however….

A

increases in direct proportion

as the dose continues to increase, the response increment diminishes and doses can finally be reaches at which no further increase in response can be achieved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is an “idealized” system

A

in vitro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
in idealized/in vitro systems, how is the relationship between drug concentration (C) and effect (E) described?
by a hyperbolic curve. equation: E = Emax * C / C + EC50
26
what is EC50
the concentration of drug at which HALF OF MAXIMAL response is observed
27
true or false EC50 is 50% of the response
false -- doesn't fit if it's a partial agonist should be - "Half of maximal response" or "drug conc that produces half of maximal effect"
28
what is Emax
the maximal response that can be produced by a drug
29
what is the formula for the relation between bound and unbound drug? explain
B = Bmax * C/ C + KD B = drug bound to receptors Bmax = total conc of receptor sites C = conc of unbound drug KD = equilibrium dissociation constant, represents the conc of FREE DRUG at which half-maximal binding is observed
30
explain what KD is
equilibrium dissociation constant represents the concentration of FREE DRUG at which HALF MAXIMAL BINDING is observed characterizes the receptor's affinity for binding the drug
31
if KD is high, what does this say about binding affinity
LOW bc KD represents the concentration of FREE DRUG at which half maximal binding is observed
32
KD characterizes the receptor's ______
AFFINITY for binding the drug (RECIPROCAL - meaning the higher the KD the lower the affinity)
33
true or false when a receptor is occupied by an agonist, the resulting conformational change is the only step required to produce a pharmacological effect
FALSE this is the first of many steps. there is a transduction process called COUPLING
34
the efficiency of receptor occupancy-response coupling is partially determined how?
by the initial conformational change in the receptor
35
explain what spare receptors are
receptors are "spare" when the maximum response can be obtained by an agonist at a concentration that DOES NOT RESULT IN FULL OCCUPANCY OF THE AVAILABLE RECEPTORS
36
TRUE OR FALSE spare receptors are different from nonspare receptors
false - they're the exact same the drug (agonist) is just very efficient bc it is able to produce a full response without occupying all of them
37
true or false spare receptors are not hidden or unavailable
true -- they're there and available, just not needed
38
true or false when spare receptors ARE occupied, they can be coupled to a response
true
39
true or false KD is the concentration of the agonist at which half the receptors are bound
TRUE
40
when the agonist binds to its receptor, it elicits what? this enables what?
a change in receptor conformation enables the receptor to bind to and activate a TRANSDUCING MOLECULE
41
In the case of having spare receptors, this means that there are less drug receptors than receptor-effector molecules TRUE OR FALSE
FALSE -- more drug receptors than receptor-effector molecules
42
a cell has 4 receptors and 4 effectors are there any spare receptors?
no.
43
what can you say when an agonist is present in concentration EQUAL TO KD
50% of the receptors will be occupied. half of the effectors will be activated, and thus a half maximal response will be produced
44
an agonist is present at a concentration equal to KD. the number of receptors increases 10 fold, and the total number of effectors remains constant. are there any spare receptors?
yes - most of them are spare this means that the drug is producing its maximal effect, even though only half of the available receptors are occupied
45
true or false when there is a situation with spare receptors, a low concentration of agonist is usually sufficient to produce a maximal response
true
46
true or false antagonists have affinity but no efficacy
true
47
explain the effect of antagonists
they bind to the receptor but do not activate it. they essentially BLOCK agonists (drugs/other endogenous regulatory molecules) from binding to and activating receptors
48
how can antagonists be divided?
reversible antagonists (competitive inhibitor) irreversible antagonists (non competitive inhibitor)
49
true or false reversible antagonists are also known as noncompetitive inhibitors
FALSE competitive. they are competing for the same binding site. therefore, increasing the concentration of the agonist can "reverse" the effects of the reversible antagonist
50
explain the difference you would expect to see in a graph of agonist effect vs agonist concentration with: -agonist -agonist + competitive inhibitor
EC50 would be pushed to the right once the competitive inhibitor enters the picture a higher dose of agonist would be needed to produce the normal agonist effects.
51
true or false EC50 is higher in the agonist than with agonist + competitive inhibitor
FALSE - higher with competitive inhibitor. more drug needed to produce same response
52
true or false for any fixed concentration of competitive antagonist, the emax will remain the same for the agonist
true -- the concentration effect curve will just shift to the right and more dose will be needed to produce the SAME EMAX
53
in a fixed concentration of competitive antagonist, a higher concentration of agonist is needed to produce a given effect (higher than the dose needed with just the agonist itself). how can the ratio of these 2 agonist concentrations be estimated?
the SCHILD EQUATION C'/C = 1 + ([I]/KI) KI = dissociation constant of the antagonist C' = agonist concentration I = concentration of antagonist
54
true or false in the presence of a fixed concentration of competitive antagonist, lower concentrations of agonist are required to produce a given effect
FALSE - higher concentrations are needed
55
the degree of inhibition produced by a competitive antagonist is dependent on what?
THE CONCENTRATION OF THE ANTAGONIST
56
true or false in the case of a reversible antagonist, increasing the concentration would increase the inhibition of agonist
true
57
what is a source of variability in clinical response to a competitive antagonist?
the concentration of agonist that is competing for binding to the receptors the higher the concentration of the agonist, the better the response
58
phenoxybenzamine
will destroy the receptor
59
under circumstances where there is only agonist, only agonists can bind to the receptor. when all the receptors are saturated, what do we see?
the maximal effect (EMAX)
60
TRUE OR FALSE antagonists bind to receptors, but do not activate those receptors
true
61
true or false when there is both agonist and antagonist, they can both bind to the receptor
true
62
in the presence of competitive antagonists, the maximum effect will be diminished. is there any way to over come this and still produce the maximum effect?
yes -- by adding more agonist
63
true or false even at very low concentrations of reversible antagonist, the efficacy is still diminished
FALSE if there is a lot of agonist, little amounts of competitive antagonist won't affect the efficacy at higher concentrations, efficacy will eventually start to decrease
64
true or false if there is a high enough concentration of competitive antagonist, ALL of the agonist may be displaced and replaced with antagonist
true
65
true or false in the presence of noncompetitive antagonist, increasing the concentration of agonist won't do anything
true
66
true or false in the case of noncompetitive/irreversible antagonists, the antagonist's affinity for the receptor may be so high that, for practical purposes, the receptor is UNAVAILABLE for binding of agonist
true
67
give an example of irreversible antagonist
they produce covalent bonds with the receptor -- irreversible effects (phenoxybenzamine)
68
is EMAX decreased in the case of noncompetitive antagonists?
YES at a certain point, when a lot of receptors are occupied by antagonist, the # of remaining unoccupied receptors may be too low for the agonist to elicit a maximal response (EVEN AT HIGH CONCENTRATION)
69
true or false with noncompetitive inhibitor, EC50 increases
false it may remain the same
70
true or false covalent binding is an example of a competitive antagonist
FALSE -- noncompetitive/irreversible
71
in what case would a lower dose of irreversible antagonist still allow the achievement of a maximum response to the agonist?
if spare receptors are present
72
when all receptors have been saturated with an irreversible antagonist, the addition of MORE AGONIST will NOT re-establish the response TRUE OR FALSE
TRUE
73
true or false an agonist is unable to displace an irreversible antagonist, even at very high concentrations of agonist
true
74
give a specific example of an irreversible antagonist and how it works
Phenoxybenzamine an irreversible alpha adrenoceptor antagonist. used to control hypertension caused by catecholamines released from a tumor of the adrenal medulla
75
give the name for a tumor of the adrenal medulla. what drug can be used to treat it?
pheochromocytoma phenoxybenzamine -- an irreversible alpha-adrenoceptor antagonist
76
give an example of how the irreversible antagonist - phenoxybenzamine - provides a therapeutic advantage
even when the administration of phenoxybenzamine lowers, blood pressure will still be maintained, even when the tumor releases very large amounts of catecholamine (bc it is an irreversible antagonist!!)
77
explain a major therapeutic disadvantage of the irreversible antagonist - phenoxybenzamine
overdose can cause major issues if the blockade of the alpha-adrenoceptor cannot be overcome, the excess effects of the drug must be antagonized "physiologically" -- by using a pressor agent (anti hypotensive agent) that does NOT act via alpha receptors catecholamines cannot displace phenoxybenzamine to combat its function bc it is an IRREVERSIBLE antagonist
78
what happens when catecholamines bind to alpha adrenoceptors?
catecholamines act as agonists to stimulate an increase in blood pressure
79
what happens in the case of a patient with pheochromocytoma
this adrenal medulla tumor will secrete excess catecholamines these act as agonists to the alpha adrenoceptor and cause an excess increase in blood pressure
80
true or false catecholamines can displace phenoxybenzamine from the alpha adrenoceptors
FALSE phenoxybenzamine is an irreversible antagonist and thus cannot be displaced by agonist
81

Pharmacology Midterm (edit) (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions